BioAge Labs (BIOA) Operating Leases (2025 - 2026)
BioAge Labs (BIOA) posted Operating Leases of $2.2 million for Q1 2026, down 4.33% sequentially from $2.3 million in Q4 2025, and down 12.79% YoY from $2.6 million in Q1 2025.
BioAge Labs (BIOA) Operating Leases (2025 - 2026) Analysis & Trends
BioAge Labs has reported Operating Leases for 2 years, with the latest figure at $2.2 million in Q1 2026.
- Quarterly Operating Leases fell 12.79% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (down 12.79% YoY) and the FY2025 annual result came in at $2.3 million, changed N/A from the prior year.
- Operating Leases declined to $2.2 million in Q1 2026 per BIOA's latest filing, from $2.3 million in the prior quarter.
- Over five years, Operating Leases peaked at $2.6 million in Q1 2025 and troughed at $2.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | BioAge Labs | 437.18 Mn | 437.18 Mn | -14.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.12 Mn |
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 2.33 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 2.56 Mn |